STOCKWATCH
·
Pharmaceuticals
Disruption30 Apr 2026, 05:41 pm

Panacea Biotec subsidiary's oncology lab fire, operations disrupted

AI Summary

Panacea Biotec Ltd informed about a fire incident on April 30, 2026, at its wholly-owned subsidiary, Panacea Biotec Pharma Limited's (PBPL) Oncology Quality Control Laboratory in Baddi, Himachal Pradesh. The fire, caused by a short circuit, was controlled internally. There were no human casualties or injuries. The operations of the said Oncology Facility are temporarily disrupted for an estimated period of 5 to 7 days. PBPL is assessing the extent of loss/damage, but it is not expected to have a material impact on the Company's financials. The facility has adequate insurance coverage, and the insurance company has been notified.

Key Highlights

  • Fire occurred at subsidiary's Oncology Quality Control Laboratory on April 30, 2026.
  • Operations of the oncology facility are temporarily disrupted for 5-7 days.
  • No human casualties or injuries reported from the incident.
  • Loss/damage is covered by insurance and not expected to be material financially.
PANACEABIO
Pharmaceuticals
PANACEA BIOTEC LTD.

Price Impact